Advisory: Alert from FN Media Group wrongly tagged to multiple companies withdrawn
An alert on FN Media Group's Acute Myeloid Leukemia market
report was inadvertently tagged to Acutinium Pharmaceuticals
ATNM.A , Bio Path Holdings BPTH.O , Bristol-Myers Squibb
BMY.N , Sellas Life Sciences Group SLS.O and Longeveron
LGVN.O and has been withdrawn.
There will be no substitute.
STORY_NUMBER: urn:newsml:reuters.com:*:nTUA1KRCHP
STORY_DATE: 17/06/2024
STORY_TIME:[01:45:02 PM GMT]
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses